<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000693550"><TermName>nonspecific immunomodulating agent</TermName><TermPronunciation>(non-speh-SIH-fik IH-myoo-noh-MOD-yoo-lay-ting AY-jent)</TermPronunciation><TermDefinition><DefinitionText>A substance that affects the immune system in a general way and may help the body fight cancer, infection, or other diseases. Nonspecific immunomodulating agents include BCG and levamisole.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000733157" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nonspecific immunomodulating agent&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733156" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;sustancia inmunomoduladora no específica&quot;" language="es" id="_4"/><SpanishTermName>sustancia inmunomoduladora no específica</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que afecta el sistema inmunitario en general y puede ayudar al cuerpo a combatir el cáncer, las infecciones y otras enfermedades.   Las sustancias inmunomoduladoras no especííficas son el BCG y el levamisol.</DefinitionText><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2011-08-22</DateFirstPublished><DateLastModified>2012-11-21</DateLastModified></GlossaryTerm>
